Jane Street
CPIX icon

Jane Street’s Cumberland Pharmaceuticals CPIX Stock Holding History

Jane Street’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$203K Buy
25,900
+4,700
+22% +$34.1K ﹤0.01% 10051
2026
Q2 		$137K Buy
21,200
+8,400
+66% +$40.3K ﹤0.01% 10411
2026
Q1 		$41.6K Buy
+12,800
New +$49.3K ﹤0.01% 11030

Other funds holding CPIX

Diversified Trust
Diversified Trust Memphis, Tennessee $4.69B AUM 22.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jane Street's CPIX Position: Q3 2026 in Review

Jane Street increased its Cumberland Pharmaceuticals (CPIX) stake by 42% in Q3 2026, buying an estimated $173K and bringing the position to 80,592 shares worth $631K. The position accounts for ﹤0.01% of the portfolio, ranked #7493.

Jane Street first reported a position in CPIX in Q2 2013 and has held it in 4 quarters since. 18 funds tracked by Wall St. Rank hold CPIX as of Q3 2026.

  • Jane Street held 80,592 shares of Cumberland Pharmaceuticals worth $631K as of Q3 2026.
  • Jane Street bought 23,851 Cumberland Pharmaceuticals shares in Q3 2026, an estimated $173K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7493 holding.
  • Jane Street first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • 18 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.